Overview

Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.

Status:
Completed
Trial end date:
2021-06-08
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy of IFX-1 treatment as replacement for glucocorticoid (GC) therapy in subjects with GPA and MPA.
Phase:
Phase 2
Details
Lead Sponsor:
InflaRx GmbH
Collaborator:
IQVIA
Treatments:
Glucocorticoids
Prednisone
Vilobelimab